Although the MNA-SF's overall nutritional screening seems to have little predictive ability for common complications in this non-elderly LC cohort, certain indicators, such as serum albumin and BMI, may be able to help identify patients who are at risk for particular adverse events. This evidence concerns the gene ALB and laryngotracheoesophageal cleft.